يحاول ذهب - حر

GST To Have Constructive Effect On The Pharma And Healthcare Sectors

July 2017

|

Bio Spectrum

Though healthcare and pharma sectors hailed the announcement of GST rates, by saying that GST will encourage local manufacturing sector to step into producing products that will be more affordable for the local consumers. But with introduction of GST ayurvedic medicines will be taxed at 12 per cent from the current tax rate of 7 per cent, which has disappointed the Ayurvedic medicines industry badly.

- Nitin Konde

GST To Have Constructive Effect On The Pharma And Healthcare Sectors

 Though healthcare and pharma sectors hailed the announcement of GST rates, by saying that GST will encourage local manufacturing sector to step into producing products that will be more affordable for the local consumers. But with introduction of GST ayurvedic medicines will be taxed at 12 per cent from the current tax rate of 7 per cent, which has disappointed the Ayurvedic medicines industry badly.

India is a big hunting ground for the pharmaceutical sector; it is the largest producer of generic medicines and its pharmaceutical sector is ranked 3rd in terms of volume and 14th in terms of value. These stats clearly show the potential of this mammoth industry and with the continuous rise in population, pharmaceutical and healthcare sector of the country are expected to grow in multiple folds. According to the experts, this sector has seen a massive growth and it is expected to reach US $150 billion mark by end of 2017 from $80 billion in 2012. Government of India is all set to launch the much awaited Goods and Services Tax (GST) on July 1, 2017 and this regime might prove a game changer for all the sectors including pharmaceuticals and healthcare.

Presently, GST has become the centre of attraction for every sector, it has not only caught the eyeballs of business honchos but it has also revamped the entire tax structure of the country. The role out of GST would benefit most of the sectors and make the taxation process easier as it will replace a number of different taxes and duties.

The Indian Healthcare Industry is now among of the major sectors with respect to revenue and to employment. As the expenditure on the Healthcare increases, so do revenues from taxes. Recently, the Government of India decided for the implementation of GST, which would subsume various taxes of the complex tax system in the country into one uniform tax system.

المزيد من القصص من Bio Spectrum

Bio Spectrum

S&T Minister inaugurates Biotechnology Research and Innovation Council (BRIC) Secretariat

The Union Minister of (Independent State Charge) for Science and Technology (S&T) Dr Jitendra Singh recently inaugurated the Biotechnology Research and Innovation Council (BRIC) Secretariat by unveiling the inaugural curtain, marking the official opening of a new milestone in India's biotechnology journey.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

US announces $50 B in awards to strengthen rural healthcare

The Centers for Medicare & Medicaid Services (CMS) has announced that all 50 states will receive awards under the Rural Health Transformation Program, a $50 billion initiative established under President Trump's Working Families Tax Cuts legislation (Public Law 119-21) to strengthen and modernise healthcare in rural communities across the country.

time to read

1 min

February 2026

Bio Spectrum

WHO unveils Traditional Medicine Global Library

At the second WHO Global Summit on Traditional Medicine, jointly organised with the Government of India, concluding recently in New Delhi, WHO unveiled the Traditional Medicine (TM) Global Library (GL), a first-of-its-kind digital platform consolidating 1.6 million resources on TM, from scientific studies to indigenous knowledge.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Telangana sets global ambition with Life Sciences Policy 2026-30 targeting $25 B investments

The Government of Telangana unveiled its Next-Gen Life Sciences Policy 2026-30 at the World Economic Forum Annual Meeting in Davos, signalling the State's intent to play a far more consequential role in shaping the future of global healthcare, advanced therapeutics, and sustainable bio-manufacturing.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

WHO reveals major equity gaps in human genomics research

The World Health Organization (WHO) has published a new global analysis of human genomics in clinical research, covering more than three decades of studies registered between 1990 and 2024.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Biotium launches GlycoLiner Cell Surface Glycoprotein Labeling Kits

US-based Biotium, a leading innovator in fluorescent dyes and life science reagents, has announced the launch of GlycoLiner Cell Surface Glycoprotein Labeling Kits for rapid, selective, and covalent labeling of cell surface glycoproteins.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Bruker consolidates ownership of TOFWERK in expansion of mass spectrometry portfolio

Bruker Corporation has announced the acquisition of an additional 60 per cent ownership stake in TOFWERK AG, a Switzerland-based innovator in ultra-fast time-of-flight (TOF) mass spectrometry technology for small molecule applied markets, consolidating Bruker's ownership to 100 per cent.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

India & Australia develop precision nano-injection platform for breast cancer drug delivery

Researchers from the Indian Institute of Technology Madras (IIT-M), Monash University and Deakin University, Australia, have developed a cutting-edge nano-injection drug delivery platform that has the potential to make breast cancer treatment safer and more effective.

time to read

1 min

February 2026

Bio Spectrum

Agilent opens India Refurbishment Centre in Manesar

Agilent Technologies Inc., a global leader in life sciences, diagnostics, and applied chemical markets, has announced the inauguration of its India Refurbishment Centre at its LEED Platinum-certified facility in Manesar, Haryana.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Yashoda Medicity appoints Dr Rajinder Kumar as Unit Head, Department of Neurosurgery

Yashoda Medicity, one of the leading hospitals in the Delhi NCR, has appointed Prof. Dr Rajinder Kumar as Principal Director & Unit Head, Neurosurgery at the Yashoda Institute of Neurosciences.

time to read

1 min

February 2026

Translate

Share

-
+

Change font size